Suppr超能文献

早期插管与重症 COVID-19 患者的临床结局:系统评价和荟萃分析。

Early intubation and clinical outcomes in patients with severe COVID-19: a systematic review and meta-analysis.

机构信息

Division of Healthcare Technology Assessment Research, National Evidence-Based Healthcare Collaborating Agency, Seoul, Republic of Korea.

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, National Medical Center, Seoul, Republic of Korea.

出版信息

Eur J Med Res. 2022 Nov 3;27(1):226. doi: 10.1186/s40001-022-00841-6.

Abstract

BACKGROUND

Evidence regarding the timing of the application of mechanical ventilation among patients with severe coronavirus disease (COVID-19) is insufficient. This systematic review and meta-analysis aimed to evaluate the effectiveness of early intubation compared to late intubation in patients with severe and critical COVID-19.

METHODS

For this study, we searched the MEDLINE, EMBASE, and Cochrane databases as well as one Korean domestic database on July 15, 2021. We updated the search monthly from September 10, 2021 to February 10, 2022. Studies that compared early intubation with late intubation in patients with severe COVID-19 were eligible for inclusion. Relative risk (RR) and mean difference (MD) were calculated as measures of effect using the random-effects model for the pooled estimates of in-hospital mortality, intensive care unit (ICU) length of stay (LOS), duration of mechanical ventilation (MV), hospital LOS, ICU-free days, and ventilator-free days. Subgroup analysis was performed based on the definition of early intubation and the index time. To assess the risk of bias in the included studies, we used the Risk of Bias Assessment tool for Non-randomized studies 2.0.

RESULTS

Of the 1523 records identified, 12 cohort studies, involving 2843 patients with severe COVID-19 were eligible. There were no differences in in-hospital mortality (8 studies, n = 795; RR 0.91, 95% CI 0.75-1.10, P = 0.32, I = 33%), LOS in the ICU (9 studies, n = 978; MD -1.77 days, 95% CI -4.61 to 1.07 days, P = 0.22, I = 78%), MV duration (9 studies, n = 1,066; MD -0.03 day, 95% CI -1.79 to 1.72 days, P = 0.97, I = 49%), ICU-free days (1 study, n = 32; 0 day vs. 0 day; P = 0.39), and ventilator-free days (4 studies, n = 344; MD 0.94 day, 95% CI -4.56 to 6.43 days, P = 0.74, I = 54%) between the early and late intubation groups. However, the early intubation group had significant advantage in terms of hospital LOS (6 studies, n = 738; MD -4.32 days, 95% CI -7.20 to -1.44 days, P = 0.003, I = 45%).

CONCLUSION

This study showed no significant difference in both primary and secondary outcomes between the early intubation and late intubation groups. Trial registration This study was registered in the Prospective Register of Systematic Reviews on 16 February, 2022 (registration number CRD42022311122).

摘要

背景

关于严重冠状病毒病(COVID-19)患者机械通气应用时机的证据不足。本系统评价和荟萃分析旨在评估与晚期插管相比,早期插管在严重和危重症 COVID-19 患者中的疗效。

方法

为了这项研究,我们于 2021 年 7 月 15 日在 MEDLINE、EMBASE 和 Cochrane 数据库以及一个韩国国内数据库中进行了检索。从 2021 年 9 月 10 日到 2022 年 2 月 10 日,我们每月更新一次搜索。符合纳入标准的研究为比较严重 COVID-19 患者早期插管与晚期插管的研究。使用随机效应模型计算住院死亡率、重症监护病房(ICU)住院时间(LOS)、机械通气(MV)持续时间、医院 LOS、ICU 无天数和呼吸机无天数的汇总估计值的相对风险(RR)和平均差异(MD)。根据早期插管的定义和指标时间进行亚组分析。使用非随机研究 2.0 风险偏倚评估工具评估纳入研究的风险偏倚。

结果

在确定的 1523 条记录中,有 12 项队列研究,共纳入 2843 例严重 COVID-19 患者符合条件。在住院死亡率方面,两组间无差异(8 项研究,n=795;RR 0.91,95%CI 0.75-1.10,P=0.32,I=33%)、ICU LOS(9 项研究,n=978;MD-1.77 天,95%CI-4.61 至 1.07 天,P=0.22,I=78%)、MV 持续时间(9 项研究,n=1066;MD-0.03 天,95%CI-1.79 至 1.72 天,P=0.97,I=49%)、ICU 无天数(1 项研究,n=32;0 天与 0 天;P=0.39)和呼吸机无天数(4 项研究,n=344;MD 0.94 天,95%CI-4.56 至 6.43 天,P=0.74,I=54%)。然而,早期插管组在住院 LOS 方面有显著优势(6 项研究,n=738;MD-4.32 天,95%CI-7.20 至-1.44 天,P=0.003,I=45%)。

结论

本研究显示,早期插管组和晚期插管组在主要和次要结局方面均无显著差异。试验注册本研究于 2022 年 2 月 16 日在系统评价前瞻性登记处注册(登记号 CRD42022311122)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b63/9632039/caab6bd03dc2/40001_2022_841_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验